Hyaluronic acid–paclitaxel: Effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts

I De Stefano, A Battaglia, GF Zannoni… - Cancer chemotherapy …, 2011 - Springer
Abstract Purpose Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are
overexpressed in a wide variety of cancers including ovarian tumors, and HA-bioconjugates …
被引用次数：71 相关文章

Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts.

I De Stefano, A Battaglia, GF Zannoni… - Cancer …, 2010 - europepmc.org
Purpose Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are overexpressed in a
wide variety of cancers including ovarian tumors, and HA-bioconjugates have been …

Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts

I Stefano, A Battaglia, GF Zannoni, MG Prisco… - Cancer Chemotherapy …, 2011 - infona.pl
Purpose Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are overexpressed in a
wide variety of cancers including ovarian tumors, and HA-bioconjugates have been …

[引用][C] Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts

I DE STEFANO, A BATTAGLIA… - Cancer …, 2011 - pascal-francis.inist.fr
Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human
ovarian cancer xenografts CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts

I De Stefano, A Battaglia, GF Zannoni… - Cancer …, 2011 - search.proquest.com
Abstract Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are overexpressed in a
wide variety of cancers including ovarian tumors, and HA-bioconjugates have been …
[PDF] core.ac.uk

[PDF][PDF] Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts

I Stefano, A Battaglia, GF Zannoni, M Grazia, AF Prisco… - core.ac.uk
ABSTRACT Purpose. Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are
overexpressed in a wide variety of cancers including ovarian tumours, and HA …

Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts.

I Stefano, A Battaglia, G Zannoni… - Cancer …, 2011 - search.ebscohost.com
Abstract Purpose: Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are
overexpressed in a wide variety of cancers including ovarian tumors, and HA-bioconjugates …
[PDF] academia.edu

[PDF][PDF] Hyaluronic acid–paclitaxel: eVects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts

I De Stefano, A Battaglia, GF Zannoni… - Cancer Chemother …, 2011 - academia.edu
Abstract Purpose Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are
overexpressed in a wide variety of cancers including ovarian tumors, and HA-bioconjugates …
[PDF] researchgate.net

[PDF][PDF] HYALURONIC ACID–PACLITAXEL: EFFECTS OF INTRAPERITONEAL ADMINISTRATION AGAINST CD44 (+) HUMAN OVARIAN CANCER XENOGRAFTS.

I De Stefano, A Battaglia, GF Zannoni, MG Prisco… - researchgate.net
ABSTRACT Purpose. Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are
overexpressed in a wide variety of cancers including ovarian tumours, and HA …
[PDF] hal.science

[PDF][PDF] Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44 (+) human ovarian cancer xenografts

I Stefano, A Battaglia, GF Zannoni, MG Prisco… - Cancer Chemotherapy …, 2010 - hal.science
ABSTRACT Purpose. Hyaluronan (HA)-receptors (mainly CD44 and RHAMM) are
overexpressed in a wide variety of cancers including ovarian tumours, and HA …